{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:46:46Z","timestamp":1777949206257,"version":"3.51.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite the common use of opioids in patients with inflammatory bowel disease (IBD), there are limited studies on the prevalence of chronic opioid use in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a nationwide Danish register-based study to examine the prevalence proportion of chronic opioid use in patients with IBD from 1996 to 2021. Analysis was performed for patients with Crohn\u2019s disease (CD) and ulcerative colitis (UC) and stratified by sex and age groups of young adults (18-39\u2009years), adults (40-59\u2009years), and elderly (+60\u2009years).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 51\u200a837 patients with IBD were identified. The prevalence proportion of chronic opioid use increased from 1996 and reached the highest point at 14.26% (95% confidence interval [CI], 13.67%-14.84%) for patients with CD in 2011 and 8.21% (95% CI, 7.88%-8.54%) in patients with UC in 2012. Subsequently, the prevalence proportion of chronic opioid use decreased to 8.88% (95% CI, 8.41%-9.35%) in patients with CD and 4.96% (95% CI, 4.70%-5.21%) in patients with UC by 2021. Throughout the 25-year period, female patients had higher prevalence proportion of chronic opioid use compared with that of male patients. Elderly patients had higher prevalence proportion of chronic opioid use compared with that of adult and young adult patients<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussions<\/jats:title>\n                    <jats:p>Many patients with IBD rely on chronic opioid use as part of their pain management. Further investigations are needed to study the complications and sequelae of chronic opioid use in patients with IBD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izaf308","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:51:18Z","timestamp":1764075078000},"page":"922-928","source":"Crossref","is-referenced-by-count":1,"title":["The Prevalence of Chronic Opioid Use in Patients With Inflammatory Bowel Disease: A Nationwide Danish Register-Based Study Over a 25-Year Period of Time"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1044-8003","authenticated-orcid":false,"given":"Jennifer","family":"Youn","sequence":"first","affiliation":[{"name":"Department of Medicine, Tufts Medical Center , Boston, MA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7634-6812","authenticated-orcid":false,"given":"Jan","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Center of Clinical Epidemiology, Odense University Hospital , Odense,","place":["Denmark"]},{"name":"Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark , Odense,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5184-4311","authenticated-orcid":false,"given":"Erantis","family":"S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Center of Clinical Epidemiology, Odense University Hospital , Odense,","place":["Denmark"]},{"name":"Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark , Odense,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9765-7321","authenticated-orcid":false,"given":"Mette","family":"Wod","sequence":"additional","affiliation":[{"name":"Center of Clinical Epidemiology, Odense University Hospital , Odense,","place":["Denmark"]},{"name":"Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark , Odense,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2720-4404","authenticated-orcid":false,"given":"Sonia","family":"Friedman","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Tufts Medical Center , Boston, MA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-3033","authenticated-orcid":false,"given":"Bente Mertz","family":"N\u00f8rg\u00e5rd","sequence":"additional","affiliation":[{"name":"Center of Clinical Epidemiology, Odense University Hospital , Odense,","place":["Denmark"]},{"name":"Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark , Odense,","place":["Denmark"]},{"name":"Division of Gastroenterology and Hepatology, Tufts Medical Center , Boston, MA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"2026050317365337000_izaf308-B1","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.3748\/WJG.V16.I25.3168","article-title":"Impact of pain on health-related quality of life in patients with inflammatory bowel disease","volume":"16","author":"Schirbel","year":"2010","journal-title":"World J Gastroenterol"},{"key":"2026050317365337000_izaf308-B2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/01.MIB.0000440983.86659.81","article-title":"The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model","volume":"20","author":"Devlen","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2026050317365337000_izaf308-B3","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/J.CROHNS.2014.03.005","article-title":"IBD and health-related quality of life\u2014discovering the true impact","volume":"8","author":"L\u00f6nnfors","year":"2014","journal-title":"J Crohns Colitis"},{"key":"2026050317365337000_izaf308-B4","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.3390\/JCM11154269","article-title":"Abdominal pain in inflammatory bowel diseases: a clinical challenge","volume":"11","author":"Wils","year":"2022","journal-title":"J Clin Med"},{"key":"2026050317365337000_izaf308-B5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/APT.13475","article-title":"Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn\u2019s disease","volume":"43","author":"Shah","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2026050317365337000_izaf308-B6","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/J.CGH.2016.01.015","article-title":"Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis","volume":"14","author":"Shah","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026050317365337000_izaf308-B7","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/IBD.20848","article-title":"Pain and inflammatory bowel disease","volume":"15","author":"Bielefeldt","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"2026050317365337000_izaf308-B8","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1046\/J.1440-1746.2001.02468.X","article-title":"Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristics","volume":"16","author":"Edwards","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"2026050317365337000_izaf308-B9","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/IBD.21806","article-title":"Narcotic use for inflammatory bowel disease and risk factors during hospitalization","volume":"18","author":"Long","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"2026050317365337000_izaf308-B10","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/J.CGH.2019.12.024","article-title":"Exposure to intravenous opioids is associated with future exposure to opioids in hospitalized patients with inflammatory bowel diseases","volume":"18","author":"Dalal","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026050317365337000_izaf308-B11","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/AJG.2012.218","article-title":"Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREATTM registry","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"2026050317365337000_izaf308-B12","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/AJG.2014.230","article-title":"The prevalence and predictors of opioid use in inflammatory bowel disease: a population-based analysis","volume":"109","author":"Targownik","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"2026050317365337000_izaf308-B13","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/J.CGH.2017.10.022","article-title":"Increasing prescription of opiates and mortality in patients with inflammatory bowel diseases in England","volume":"16","author":"Burr","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026050317365337000_izaf308-B14","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/IBD\/IZAC021","article-title":"The relationship between opioid use and healthcare utilization in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"28","author":"Sheehan","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"2026050317365337000_izaf308-B15","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1093\/IBD\/IZAD244","article-title":"Inflammatory bowel disease in adults and elderly: the use of selected non-IBD medication examined in a nationwide cohort study","volume":"30","author":"Lund","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"2026050317365337000_izaf308-B16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.14309\/AJG.0000000000002497","article-title":"Older adult-onset of inflammatory bowel diseases is associated with higher utilization of analgesics: a nationwide cohort study","volume":"119","author":"Dalal","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"2026050317365337000_izaf308-B17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/APT.18014","article-title":"The use of opioids nine months after surgery for Crohn\u2019s disease\u2014a nationwide cohort study","volume":"60","author":"N\u00f8rg\u00e5rd","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"2026050317365337000_izaf308-B18","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.14309\/AJG.0000000000003353","article-title":"Predictors for chronic opioid use in patients with inflammatory bowel disease\u2014a population based cohort study","volume":"120","author":"N\u00f8rg\u00e5rd","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"2026050317365337000_izaf308-B19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"2026050317365337000_izaf308-B20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish National Patient Register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand J Public Health"},{"key":"2026050317365337000_izaf308-B21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/S10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"2026050317365337000_izaf308-B22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/CLEP.S37587","article-title":"Existing data sources for clinical epidemiology: the Danish National Database of Reimbursed Prescriptions","volume":"4","author":"Johannesdottir","year":"2012","journal-title":"Clin Epidemiol"},{"key":"2026050317365337000_izaf308-B23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2147\/CLEP.S378003","article-title":"L. Validity of inflammatory bowel disease diagnoses in the Danish National Patient Registry: a population-based study from the North Denmark Region","volume":"14","author":"Jacobsen","year":"2022","journal-title":"Clin Epidemiol"},{"key":"2026050317365337000_izaf308-B24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/ecco-jcc\/jjw188","article-title":"European Crohn\u2019s and colitis organisation topical review on IBD in the elderly","volume":"11","author":"Sturm","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2026050317365337000_izaf308-B25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2147\/JPR.S388674","article-title":"Epidemiological factors associated with prescription of opioids for chronic non-cancer pain in adults: a country-wide, registry-based study in Denmark Spans 2004\u20132018","volume":"16","author":"Hansen","year":"2023","journal-title":"J Pain Res"},{"key":"2026050317365337000_izaf308-B26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40801-019-00163-w","article-title":"Trends of opioid utilisation in Denmark: a nationwide study","volume-title":"Drugs Real World Outcomes.","author":"Nissen","year":"2019"},{"key":"2026050317365337000_izaf308-B27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/S12877-022-03125-0\/FIGURES\/6","article-title":"Prescription opioids among older adults: ten years of data across five countries","volume":"22","author":"Hamina","year":"2022","journal-title":"BMC Geriatr"},{"key":"2026050317365337000_izaf308-B28","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/J.CGH.2020.08.041\/ASSET\/27EDDF62-8251-473E-89B3-2F5F281A1DB8\/MAIN.ASSETS\/GR4.JPG","article-title":"Opioid use among patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"19","author":"Niccum","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026050317365337000_izaf308-B29","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1089\/HEQ.2020.0062","article-title":"Treatment disparities among the black population and their influence on the equitable management of chronic pain","volume":"5","author":"Knoebel","year":"2021","journal-title":"Health Equity"},{"key":"2026050317365337000_izaf308-B30","doi-asserted-by":"publisher","first-page":"24m15339","DOI":"10.4088\/JCP.24M15339","article-title":"Geographical and socioeconomic disparities in substance and opioid use disorders among inflammatory bowel disease hospitalizations in the united states from the national inpatient sample","volume":"86","author":"Kim","year":"2025","journal-title":"J Clin Psychiatry"},{"key":"2026050317365337000_izaf308-B31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.15585\/MMWR.RR6501E1ER","article-title":"CDC guideline for prescribing opioids for chronic pain\u2013United States, 2016","volume":"65","author":"Lappin","year":"2023","journal-title":"MMWR Recomm Rep"},{"key":"2026050317365337000_izaf308-B32","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/AJP.0B013E318169D03B","article-title":"De facto long-term opioid therapy for noncancer pain","volume":"24","author":"Von Korff","year":"2008","journal-title":"Clin J Pain"},{"key":"2026050317365337000_izaf308-B33","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/PDS.1833","article-title":"Trends in long-term opioid therapy for chronic non-cancer pain","volume":"18","author":"Boudreau","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026050317365337000_izaf308-B34","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/IJE\/DYW213","article-title":"Data Resource Profile: The Danish National Prescription Registry","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2026050317365337000_izaf308-B35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1185\/03007995.2010.542136","article-title":"The prevalence, correlates and treatment of pain in the European Union","volume":"27","author":"Langley","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"2026050317365337000_izaf308-B36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/J.EJPAIN.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"Eur J Pain"},{"key":"2026050317365337000_izaf308-B37","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1093\/IBD\/IZY040","article-title":"The association between sustained poor quality of life and future opioid use in inflammatory bowel disease","volume":"24","author":"Anderson","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2026050317365337000_izaf308-B38","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/ECCO-JCC\/JJZ198","article-title":"Opioid use disorder increases 30-day readmission risk in inflammatory bowel disease hospitalizations: a nationwide matched analysis","volume":"14","author":"Charilaou","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2026050317365337000_izaf308-B39","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1093\/ECCO-JCC\/JJY062","article-title":"The impact of opioid epidemic trends on hospitalised inflammatory bowel disease patients","volume":"12","author":"Cohen-Mekelburg","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2026050317365337000_izaf308-B40","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1093\/IBD\/IZZ100","article-title":"Opioid use is associated with higher health care costs and emergency encounters in inflammatory bowel disease","volume":"25","author":"Alley","year":"2019","journal-title":"Inflamm Bowel Dis"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/5\/922\/66476677\/izaf308.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/5\/922\/66476677\/izaf308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T21:36:58Z","timestamp":1777844218000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/32\/5\/922\/8431575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,1,20]]},"published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaf308","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,1,20]]}}}